Histone Deacetylases and Their Inhibitors in Inflammatory Diseases
Overview
General Medicine
Pharmacology
Affiliations
Despite considerable research efforts, inflammatory diseases remain a heavy burden on human health, causing significant economic losses annually. Histone deacetylases (HDACs) play a significant role in regulating inflammation (via histone and non-histone protein deacetylation) and chromatin structure and gene expression regulation. Herein, we present a detailed description of the different HDACs and their functions and analyze the role of HDACs in inflammatory diseases, including pro-inflammatory cytokine production reduction, immune cell function modulation, and anti-inflammatory cell activity enhancement. Although HDAC inhibitors have shown broad inflammatory disease treatment potentials, their clinical applicability remains limited because of their non-specific effects, adverse effects, and drug resistance. With further research and insight, these inhibitors are expected to become important tools for the treatment of a wide range of inflammatory diseases. This review aims to explore the mechanisms and application prospects of HDACs and their inhibitors in multiple inflammatory diseases.
Kaszycki J, Kim M Front Immunol. 2025; 16:1529756.
PMID: 40046056 PMC: 11879833. DOI: 10.3389/fimmu.2025.1529756.
Tahghighi A, Seyedhashemi E, Mohammadi J, Moradi A, Esmaeili A, Pornour M Clin Epigenetics. 2025; 17(1):34.
PMID: 39987205 PMC: 11847397. DOI: 10.1186/s13148-025-01844-w.
Butyrate Supplementation Improves Intestinal Health and Growth Performance in Livestock: A Review.
Chen W, Ma Q, Li Y, Wei L, Zhang Z, Khan A Biomolecules. 2025; 15(1).
PMID: 39858479 PMC: 11763988. DOI: 10.3390/biom15010085.
Kim M, Lee J Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852123 PMC: 11763386. DOI: 10.3390/cimb47010008.
The Role of Chronic Inflammation in Pediatric Cancer.
Mella C, Tsarouhas P, Brockwell M, Ball H Cancers (Basel). 2025; 17(1.
PMID: 39796780 PMC: 11719864. DOI: 10.3390/cancers17010154.